Patients' preferences for connected insulin pens: a discrete choice experiment among patients with type 1 and type 2 diabetes
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This study quantified how people with diabetes value the unique features of connected insulin pens and related mobile apps, and the underlying reasons for preferring connected versus non-connected insulin pens. METHODS: A discrete choice experiment (DCE) was conducted in the USA and UK to elicit preferences of adults (≥ 18 years) with type 1 or 2 diabetes for attributes of insulin pens. Attributes included device type, dosing support, glucose monitoring, additional app features, and data sharing. Relative attribute importance (RAI) scores were calculated to capture the relative importance of an attribute. Predicted choice probabilities were obtained to compare different profiles for connected and non-connected insulin pens. RESULTS: The DCE was completed by 540 participants (58.9% male; 90.7% Caucasian; mean age, 58.3 years; 69.4% type 2 diabetes). Participants most valued the possibility of using a connected insulin pen with dosing support and automated dose logging (RAI = 39.9%), followed by automatic transfer of glucose levels (RAI = 29.0%), additional features of tracking diet and physical activity (RAI = 14.6%), data sharing (RAI = 13.6%), and device type (RAI = 2.9%). All profiles of connected insulin pens were preferred over a non-connected pen (p < 0.001), and pen profiles with advanced features were preferred over those without (p < 0.001). Preferences differed by age but not diabetes type, country of residence, or insulin regimen. CONCLUSION: People with diabetes in the USA and UK prefer connected over non-connected insulin pens due largely to the availability of automated logging of dose and glucose levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These pens and pen caps are useful to people with diabetes for realtime insulin dosing and allow clinicians to retrospectively review the insulin delivery times and, in some cases, doses and glucose data to make informed insulin dose adjustments (153).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [153]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A law of comparative judgment.
Thurstone, L. L. (1927) · Psychological Review · doi:10.1037/h0070288 · Cited by 5,210
Bridges, J. F. P., Hauber, A. B., Marshall, D., Lloyd, A., Prosser, L. A., Regier, D. A., Johnson, F. R., & Mauskopf, J. (2011) · Value in Health · doi:10.1016/j.jval.2010.11.013 · Cited by 2,029 · cited 2×
“Following best practices for preference research [25, 27], the study was conducted in three phases: a targeted literature review to identify attributes to include in the DCE, qualitative interviews to inform and test the final design of the DCE, and a main DCE.”
MethodA latent class model for discrete choice analysis: contrasts with mixed logit
Greene, W. H., & Hensher, D. A. (2003) · Transportation Research Part B: Methodological · doi:10.1016/s0191-2615(02)00046-2 · Cited by 1,893 · cited 1×
“This opt-out behavior was represented by a finite mixture of utility values associated with the non-connected pen, making the RCL a specific case of latent class analysis [38].”
MethodReed Johnson, F., Lancsar, E., Marshall, D., Kilambi, V., Mühlbacher, A., Regier, D. A., Bresnahan, B. W., Kanninen, B., & Bridges, J. F. P. (2013) · Value in Health · doi:10.1016/j.jval.2012.08.2223 · Cited by 1,799
The structure of random utility models
Manski, C. F. (1977) · Theory and Decision · doi:10.1007/bf00133443 · Cited by 1,724
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455 · cited 1×
“Understanding the willingness of people with diabetes to switch from a non-connected to a connected insulin pen and the drivers of such decisions can help tailor the design of diabetes technologies to meet the needs of people using them [17, 18].”
Using conjoint analysis to elicit preferences for health care
Ryan, M. (2000) · BMJ · doi:10.1136/bmj.320.7248.1530 · Cited by 938 · cited 1×
“A DCE was conducted between March 24 and July 4, 2021, to elicit preferences of adults (aged ≥ 18 years) with diabetes for attributes of connected insulin pens [25, 26].”
MethodSample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide
de Bekker-Grob, E. W., Donkers, B., Jonker, M. F., & Stolk, E. A. (2015) · The Patient - Patient-Centered Outcomes Research · doi:10.1007/s40271-015-0118-z · Cited by 925
Discrete Choice Experiments in Health Economics: Past, Present and Future
Soekhai, V., de Bekker-Grob, E. W., Ellis, A. R., & Vass, C. M. (2019) · PharmacoEconomics · doi:10.1007/s40273-018-0734-2 · Cited by 797 · cited 1×
“For example, a discrete choice experiment (DCE) can be used to elicit the effect that unique features of insulin pens have on the likelihood that people with diabetes would prefer a connected pen over a non-connected pen [19, 20].”
Background6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744
Coast, J., Al‐Janabi, H., Sutton, E. J., Horrocks, S. A., Vosper, A. J., Swancutt, D. R., & Flynn, T. N. (2012) · Health Economics · doi:10.1002/hec.1739 · Cited by 587 · cited 1×
“This study benefitted from a best-practice mixed methods design [49–51], wherein a targeted literature search was used to select attributes and levels for the DCE, after which the DCE was tested and refined in two rounds of qualitative interviews and then finally used in a main study [49].”
MethodChomutare, T., Fernandez-Luque, L., Årsand, E., & Hartvigsen, G. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1874 · Cited by 451
Lancsar, E., & Louviere, J. (2006) · Health Economics · doi:10.1002/hec.1104 · Cited by 400 · cited 2×
“Following best practices for preference research [25, 27], the study was conducted in three phases: a targeted literature review to identify attributes to include in the DCE, qualitative interviews to inform and test the final design of the DCE, and a main DCE.”
MethodShan, R., Sarkar, S., & Martin, S. S. (2019) · Diabetologia · doi:10.1007/s00125-019-4864-7 · Cited by 339 · cited 1×
“Hence, more advanced technological aids with added features, such as bolus advisors, are becoming available to optimise insulin delivery, improve adherence, and reduce dosing errors [14].”
BackgroundFleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetes Care · doi:10.2337/dci19-0062 · Cited by 306
Davies, M. J., Gagliardino, J. J., Gray, L. J., Khunti, K., Mohan, V., & Hughes, R. (2013) · Diabetic Medicine · doi:10.1111/dme.12128 · Cited by 294 · cited 1×
“Although insulin is effective for managing diabetes and therefore glycemic control [2, 3], insulin dosing is frequently suboptimal because people with diabetes miss or mistime doses or administer the wrong dose [4, 5].”
BackgroundRationalising the ‘irrational’: a think aloud study of discrete choice experiment responses
Ryan, M., Watson, V., & Entwistle, V. (2009) · Health Economics · doi:10.1002/hec.1369 · Cited by 248
Johnson, F. R., Yang, J.-C., & Reed, S. D. (2019) · Value in Health · doi:10.1016/j.jval.2018.07.876 · Cited by 233 · cited 1×
“the internal validity of responses were added following the 12 experimental choice tasks [32].”
MethodDesigning a Stated Choice Experiment: The Value of a Qualitative Process
Kløjgaard, M. E., Bech, M., & Søgaard, R. (2012) · Journal of Choice Modelling · doi:10.1016/s1755-5345(13)70050-2 · Cited by 181
The first time is the hardest: A test of ordering effects in choice experiments
Carlsson, F., Mørkbak, M. R., & Olsen, S. B. (2012) · Journal of Choice Modelling · doi:10.1016/s1755-5345(13)70051-4 · Cited by 177 · cited 1×
“The order of the “additional features” and “data sharing” attributes was randomized between participants to avoid ordering effects [30, 31].”
BackgroundIncluding Opt-Out Options in Discrete Choice Experiments: Issues to Consider
Campbell, D., & Erdem, S. (2018) · Patient · doi:10.1007/s40271-018-0324-6 · Cited by 146 · cited 2×
“This model extended classical multinomial logit models for choice data to account for heterogeneity in participants’ tendency to opt into a connected pen [37].”
MethodAdolfsson, P., Hartvig, N. V., Kaas, A., Møller, J. B., & Hellman, J. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0411 · Cited by 139 · cited 1×
“Other studies have shown fewer missed doses and improved glucose control in people with diabetes using connected insulin pens [47, 48].”
ResultBeal, G. M., & Bohlen, J. M. (1956) · Increasing understanding of public problems and policies · doi:10.22004/ag.econ.17351 · Cited by 139
Guerci, B., Chanan, N., Kaur, S., Jasso-Mosqueda, J. G., & Lew, E. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0590-x · Cited by 106 · cited 1×
“Although insulin is effective for managing diabetes and therefore glycemic control [2, 3], insulin dosing is frequently suboptimal because people with diabetes miss or mistime doses or administer the wrong dose [4, 5].”
BackgroundChallenges in Diabetes Care: Can Digital Health Help Address Them?
Iyengar, V., Wolf, A., Brown, A., & Close, K. (2016) · Clinical Diabetes · doi:10.2337/diaclin.34.3.133 · Cited by 84
Digital Diabetes Management: A Literature Review of Smart Insulin Pens
Heinemann, L., Schnell, O., Gehr, B., Schloot, N. C., Görgens, S. W., & Görgen, C. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820983863 · Cited by 83 · cited 1×
“This is highlighted by the finding that approximately two-thirds of participants agreed or strongly agreed with statements that connected insulin pen systems offer improved diabetes management and simpler dose tracking over conventional paper logbooks, in agreement with other studies suggesting that connected insulin…”
BackgroundYavuz, D., Ozcan, S., & Deyneli, O. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s87935 · Cited by 80
Adu, M. D., Malabu, U. H., Malau-Aduli, A. E. O., & Malau-Aduli, B. S. (2018) · PLOS ONE · doi:10.1371/journal.pone.0208942 · Cited by 77
Munshi, M. N., Slyne, C., Greenberg, J. M., Greaves, T., Lee, A., Carl, S., Atakov-Castillo, A., & Toschi, E. (2019) · Diabetes Care · doi:10.2337/dc18-1631 · Cited by 66 · cited 1×
“Although insulin is effective for managing diabetes and therefore glycemic control [2, 3], insulin dosing is frequently suboptimal because people with diabetes miss or mistime doses or administer the wrong dose [4, 5].”
BackgroundEvidence-based Mobile Medical Applications in Diabetes
Drincic, A., Prahalad, P., Greenwood, D., & Klonoff, D. C. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.001 · Cited by 63
Gelhorn, H., Poon, J.-L., Davies, E., Paczkowski, R., Curtis, S., & Boye, K. S. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s90842 · Cited by 54
Self-citationCan Smart Pens Help Improve Diabetes Management?
Sy, S. L., Munshi, M. N., & Toschi, E. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820965600 · Cited by 54 · cited 2×
“The results of this study suggest that people with diabetes highly value the support that connected insulin pen technologies offer by integrating data on dosing and data collected from glucose monitors [16].”
BackgroundPreferences for medication attributes among patients with type 2 diabetes mellitus in the UK
Gelhorn, H. L., Stringer, S. M., Brooks, A. B., Thompson, C., Monz, B. U., Boye, K. S., Hach, T., Lund, S. S., & Palencia, R. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12091 · Cited by 52
Given, J. E., O'Kane, M. J., Bunting, B. P., & Coates, V. E. (2013) · Diabetic Medicine · doi:10.1111/dme.12130 · Cited by 48 · cited 1×
“Traditionally, people with diabetes have self-managed their disease by keeping a detailed logbook of therapeutic and lifestyle actions, but such records are often incomplete or inaccurate [9, 10].”
BackgroundBaptista, S., Trawley, S., Pouwer, F., Oldenburg, B., Wadley, G., & Speight, J. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0086 · Cited by 42
Knight, B. A., McIntyre, D. H., Hickman, I. J., & Noud, M. (2016) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-016-0356-6 · Cited by 41
Vass, C., Davison, N., Stichele, G. V., & Payne, K. (2019) · Patient · doi:10.1007/s40271-019-00391-w · Cited by 40 · cited 1×
“For example, a short video was included to illustrate connected insulin pens and help participants distinguish between attribute levels [52, 53].”
BackgroundAccuracy of Self-Monitored Blood Glucose in Type 2 Diabetes
Kazlauskaite, R., Soni, S., Evans, A. T., Graham, K., & Fisher, B. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0111 · Cited by 37 · cited 1×
“Traditionally, people with diabetes have self-managed their disease by keeping a detailed logbook of therapeutic and lifestyle actions, but such records are often incomplete or inaccurate [9, 10].”
BackgroundHeidenreich, S., Phillips-Beyer, A., Flamion, B., Ross, M., Seo, J., & Marsh, K. (2020) · Patient · doi:10.1007/s40271-020-00475-y · Cited by 37 · cited 1×
“The order of the “additional features” and “data sharing” attributes was randomized between participants to avoid ordering effects [30, 31].”
BackgroundSelf-citationGelhorn, H. L., Bacci, E. D., Poon, J. L., Boye, K. S., Suzuki, S., & Babineaux, S. M. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s109289 · Cited by 35
Self-citationAre Videos or Text Better for Describing Attributes in Stated-Preference Surveys?
Lim, S. L., Yang, J., Ehrisman, J. A., Havrilesky, L. J., & Reed, S. D. (2020) · Patient · doi:10.1007/s40271-020-00416-9 · Cited by 33 · cited 1×
“For example, a short video was included to illustrate connected insulin pens and help participants distinguish between attribute levels [52, 53].”
BackgroundAdherence to insulin treatment in diabetes: can it be improved?糖尿病患者使用胰岛素治疗的依从性:它能够得到改善吗?
Doggrell, S. A., & Chan, V. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12212 · Cited by 29 · cited 1×
“Although insulin is effective for managing diabetes and therefore glycemic control [2, 3], insulin dosing is frequently suboptimal because people with diabetes miss or mistime doses or administer the wrong dose [4, 5].”
BackgroundGomez-Peralta, F., Abreu, C., Gomez-Rodriguez, S., Cruz-Bravo, M., María-Sanchez, C., Poza, G., & Ruiz-Valdepeñas, L. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0427 · Cited by 25 · cited 1×
“Other studies have shown fewer missed doses and improved glucose control in people with diabetes using connected insulin pens [47, 48].”
ResultHealth apps usage and preferences among Saudi patients with diabetes: A survey
Rafiullah, M., & David, S. K. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13345 · Cited by 20
Insulin Administration and the Impacts of Forgetting a Dose
Brod, M. I., Pohlman, B., & Kongsø, J. H. (2013) · Patient · doi:10.1007/s40271-013-0029-9 · Cited by 19
Smythe, K., Saw, M., Mak, M., & Wong, V. (2018) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12561 · Cited by 15
Poon, J. L. (2018) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2018.06.555700 · Cited by 6
Self-citation(2004) · PubMed
Research works printed but not linked: 3
- Carson R Louviere J A common nomenclature for stated preference elicitation approaches environmental and resource Economics 2011 49 539 559
- Marschak J Binary choice constraints on random utility indicators 1959 New Haven Cowles Foundation for Research in Economics, Yale University
- McFadden D Conditional logit analysis of qualitative choice behaviour 1973 New York Academic Press
Cited by
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 288
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review
Nouwens, S. P. H., Marceta, S. M., Bui, M., van Dijk, D. M. A. H., Groothuis‐Oudshoorn, C. G. M., Veldwijk, J., van Til, J. A., & de Bekker-Grob, E. W. (2025) · PharmacoEconomics · doi:10.1007/s40273-025-01495-y · Cited by 60
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 85
Metadata
- Authors
- Seo, J., Heidenreich, S., Aldalooj, E., Poon, J. L., Spaepen, E., Eby, E. L., & Newson, R. S.
- Affiliations
- Eli Lilly (United States) (US)
- Eli Lilly (Australia) (AU)
- Corresponding author
- Newson, Rachel S.
- ORCID
- Venue
- The Patient - Patient-Centered Outcomes Research
- Published
- 2022-11-28
- Volume
- 16
- Issue
- 2
- Pages
- 127-138
- ISSN
- 1178-1653 (ISSN-L)
- 1178-1661
- PMC
- PMC9911509
- OpenAlex
- W4310172345
- Cited by
- 19
- References
- 47
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2023: 3 · 2022: 1
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- creativecommons.org/licenses/by-nc/4.0 (vor)
- Locations
- Patient (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Eli Lilly and Company (Eli lilly funded Evidera to perform the study)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
- Keywords
- connected insulin pens, type 1 diabetes, type 2 diabetes, patient preferences, mobile health apps, glucose monitoring, data sharing, relative attribute importance, age differences in preference
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Blood Glucose Self-Monitoring, Patient Preference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.